NasdaqGM - Nasdaq Real Time Price
USD
Wave Life Sciences, Inc. (WVE)
3.3650
+0.1450
(+4.50%)
At close: November 6 at 4:00:00 PM EST
3.4000
+0.0350
(+1.04%)
After hours: November 6 at 5:15:18 PM EST
Trade WVE on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
34,851,382 | 81 |
|
Sales
|
2,852,192 | 78 |
|
Net Shares Purchased (Sold)
|
31,999,190 | 159 |
|
Total Insider Shares Held
|
30.73M | -- |
|
% Net Shares Purchased (Sold)
|
-2,513.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -18,006,218 |
| % Change in Institutional Shares Held | -10.77% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| TAKANASHI KEN Director |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 5, 2026 |
| TAN AIK NA Director |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 5, 2026 |
| WAGNER HEIDI L Director |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 5, 2026 |
| RAWCLIFFE ADRIAN Director |
Sale at price 5.29 per share. | Direct | 67,183 | Aug 12, 2026 |
| WAGNER HEIDI L Director |
Sale at price 6.01 per share. | Direct | 42,070 | Aug 11, 2026 |
| TAKANASHI KEN Director |
Sale at price 6.01 per share. | Direct | 23,223 | Aug 11, 2026 |
| TAN AIK NA Director |
Sale at price 6.01 per share. | Direct | 2,596 | Aug 11, 2026 |
| WAGNER HEIDI L Director |
Conversion of Exercise of derivative security at price 5.97 per share. | Direct | 41,790 | Aug 11, 2026 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security |
Purchase at price 6.06 - 6.50 per share. | Indirect | 54,624,378 | Mar 30, 2026 |
| TAKANASHI KEN Director |
-- | Indirect | -- | Mar 23, 2026 |
| FRANCIS CHRISTOPHER JOHN Officer |
Sale at price 15.00 - 15.09 per share. | Direct | 499,593 | Feb 26, 2026 |
| FRANCIS CHRISTOPHER JOHN Officer |
Conversion of Exercise of derivative security at price 3.87 - 4.75 per share. | Direct | 141,920 | Feb 26, 2026 |
| MORAN KYLE Chief Financial Officer |
Sale at price 13.45 per share. | Direct | 48,259 | Feb 9, 2026 |
| BOLNO PAUL B. M.D. Chief Executive Officer |
Sale at price 13.45 per share. | Direct | 140,956 | Feb 9, 2026 |
| VARGEESE CHANDRA Officer |
Sale at price 13.45 per share. | Direct | 43,417 | Feb 9, 2026 |
| FRANCIS CHRISTOPHER JOHN Officer |
Sale at price 13.45 per share. | Direct | 25,326 | Feb 9, 2026 |
| MORAN KYLE Chief Financial Officer |
-- | Direct | -- | Feb 5, 2026 |
| BOLNO PAUL B. M.D. Chief Executive Officer |
-- | Direct | -- | Feb 5, 2026 |
| VARGEESE CHANDRA Officer |
-- | Direct | -- | Feb 5, 2026 |
| FRANCIS CHRISTOPHER JOHN Officer |
-- | Direct | -- | Feb 5, 2026 |
| FRANCIS CHRISTOPHER JOHN Officer |
Sale at price 15.92 - 16.70 per share. | Direct | 150,260 | Jan 2, 2026 |
| FRANCIS CHRISTOPHER JOHN Officer |
Conversion of Exercise of derivative security at price 3.14 per share. | Direct | 29,438 | Jan 2, 2026 |
| GSK PLC Beneficial Owner of more than 10% of a Class of Security |
Purchase at price 19.00 per share. | Indirect | 27,930,000 | Dec 11, 2025 |
| MORAN KYLE Chief Financial Officer |
Sale at price 13.20 - 20.25 per share. | Direct | 4,103,979 | Dec 9, 2025 |
| MORAN KYLE Chief Financial Officer |
Conversion of Exercise of derivative security at price 2.83 - 10.48 per share. | Direct | 1,539,420 | Dec 9, 2025 |
| CORRIGAN MARK Director |
Sale at price 13.09 - 14.06 per share. | Direct | 217,297 | Dec 8, 2025 |
| HENRY CHRISTIAN O Director |
Sale at price 12.75 - 18.02 per share. | Direct | 1,369,324 | Dec 8, 2025 |
| RAWCLIFFE ADRIAN Director |
Sale at price 15.00 per share. | Direct | 630,000 | Dec 8, 2025 |
| VERDINE GREGORY L Director |
Sale at price 13.09 - 14.05 per share. | Direct | 269,461 | Dec 8, 2025 |
| WAGNER HEIDI L Director |
Sale at price 13.00 - 14.00 per share. | Direct | 189,000 | Dec 8, 2025 |
| FRANCIS CHRISTOPHER JOHN Officer |
Sale at price 14.08 - 16.00 per share. | Direct | 6,427,085 | Dec 8, 2025 |
| TAN AIK NA Director |
Sale at price 12.75 - 15.00 per share. | Direct | 1,823,158 | Dec 8, 2025 |
| HENRY CHRISTIAN O Director |
Conversion of Exercise of derivative security at price 3.50 - 5.97 per share. | Direct | 440,790 | Dec 8, 2025 |
| RAWCLIFFE ADRIAN Director |
Conversion of Exercise of derivative security at price 5.97 per share. | Direct | 250,740 | Dec 8, 2025 |
| WAGNER HEIDI L Director |
Conversion of Exercise of derivative security at price 5.97 per share. | Direct | 83,580 | Dec 8, 2025 |
| FRANCIS CHRISTOPHER JOHN Officer |
Conversion of Exercise of derivative security at price 2.83 - 10.48 per share. | Direct | 2,107,183 | Dec 8, 2025 |
| TAN AIK NA Director |
Conversion of Exercise of derivative security at price 3.50 - 5.97 per share. | Direct | 578,270 | Dec 8, 2025 |
| RAWCLIFFE ADRIAN Director |
Sale at price 6.79 per share. | Direct | 109,421 | Nov 13, 2025 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security |
Purchase at price 6.69 per share. | Indirect | 6,688 | Nov 13, 2025 |
| VERDINE GREGORY L Director |
Sale at price 10.00 per share. | Direct | 100,000 | Aug 22, 2025 |
| BOLNO PAUL B. M.D. Chief Executive Officer |
Sale at price 10.10 per share. | Direct | 2,194,810 | Aug 22, 2025 |
| TAN AIK NA Director |
Sale at price 9.25 per share. | Direct | 194,250 | Aug 15, 2025 |
| TAN AIK NA Director |
Conversion of Exercise of derivative security at price 9.13 per share. | Direct | 191,730 | Aug 15, 2025 |
| HENRY CHRISTIAN O Director |
Sale at price 8.81 per share. | Direct | 85,193 | Aug 13, 2025 |
| TAKANASHI KEN Director |
-- | Direct | -- | Aug 11, 2025 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security |
-- | Indirect | -- | Aug 11, 2025 |
| TAN AIK NA Director |
-- | Direct | -- | Aug 11, 2025 |
| CORRIGAN MARK Director |
-- | Direct | -- | Aug 11, 2025 |
| HENRY CHRISTIAN O Director |
-- | Direct | -- | Aug 11, 2025 |
| RAWCLIFFE ADRIAN Director |
-- | Direct | -- | Aug 11, 2025 |
